Crowdonomics
All companies

Medical Care Technologies Inc.

Raising nowOperating

Healthcare · Mesa, AZ

Medical Care Technologies develops AI-based mobile and smart-device apps for lifestyle, wellness, diet and medical-adjacent markets, sold to consumers through global app marketplaces. All consumer apps run on paid subscription memberships, with a longer-term aim of serving regulated medical settings.

Raising nowRaising now

This company has an open fundraising round.

$0 raised
View the live round
Estimated pre-money ⓘ
$985K
As of Jun 2026 · from Reg A Offering (2026) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$50,000
Crowd $0 · Private $50K · 3 rounds since 2011
Latest share price
$0.0005
Reg A+ · Equity · Jun 2026 offering price

Financials

FY2010–FY2025 (no data for FY2012, FY2013, FY2014, FY2015, FY2016, FY2017, FY2018, FY2019, FY2020, FY2021, FY2022, FY2024) · from SEC filings · hover any figure for its source
−$2.2M
2010
−$1.9M
2011
2012no data
2013no data
2014no data
2015no data
2016no data
2017no data
2018no data
2019no data
2020no data
2021no data
2022no data
$249K
$99K
2023
2024no data
$50K
−$41K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2010 audited
FY2011 audited
FY2023
FY2025
Income statement
Revenue
—
—
$249,011
$49,819
Cost of goods sold
—
—
$107,587
$47,573
Gross margin
—
—
57%
5%
Net income
-$2,189,271
-$1,923,887
$98,587
-$41,480
Balance sheet
Cash
$391
$3,380
$75,080
$247,253
Accounts receivable
—
—
$0
$0
Total assets
$16,891
$513,921
$1,358,467
$1,871,820
Long-term debt
—
—
$58,308
$0
Total liabilities
$246,253
$652,409
$115,503
$61,897
Other
Headcount
—
—
1
1

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$985K
est. pre-money
Reg A+ · Equity · Jun 2026

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Jun 22, 2026
ClassOutstandingVotes / shareShare of totalLast price
Common Stock3,542,275,2301100.0%$0.0005Jun 2026

Shares outstanding over timein today's share terms

3.5B1.8B0
Dec 2009Jun 2026
Common StockRound opened

Changes in named holdersshares in today's terms · % of all shares at the time

Principal holders% as the filing states it, Jun 22, 2026

  • Marshall Perkins III1,980,000,000 Common Stock61.7%of
  • Carey W. Cooley200,000,000 Common Stock5.3%of
  • Marshall Perkins III1 Series A Preferred Stock—of votes

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $0 / $596KEst. pre-money $985.1K
Raised $0 / $1M
Raised $50KInvestors 1

Team

1 person
Marshall Perkins III
Chief Executive Officer, President, Secretary, Treasurer, Director

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form QUALIFJun 25, 20269999999994-26-000124
    EDGAR
  • Form 1-A/AJun 22, 20260001099910-26-000216
    EDGAR
  • Form 1-AApr 22, 20260001099910-26-000153
    EDGAR
  • Form 253G2Jul 11, 20250001099910-25-000185
    EDGAR
  • Form 253G2Jul 3, 20250001099910-25-000181
    EDGAR
  • Form QUALIFApr 11, 20259999999994-25-000071
    EDGAR
  • Form 1-A POSApr 10, 20250001099910-25-000121
    EDGAR
  • Form 1-A POSMar 27, 20250001099910-25-000110
    EDGAR
Source: SEC EDGARCIK 0001404593NVShare price $0.0005Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.